相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A 6-gene signature identifies four molecular subgroups of neuroblastoma
Frida Abel et al.
CANCER CELL INTERNATIONAL (2011)
Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group
Andrew L. Gilman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Joelel Vermeulen et al.
LANCET ONCOLOGY (2009)
Cell lines from MYCN transgenic murine turnours reflect the molecular and biological characteristics of human neuroblastorna
Andy J. Cheng et al.
EUROPEAN JOURNAL OF CANCER (2007)
Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome
Matthias Fischer et al.
CLINICAL CANCER RESEARCH (2006)
Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors
JK Stauffer et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma
T Khan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the aurora kinase inhibitor VX-680
MA Young et al.
CANCER RESEARCH (2006)
Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma
KC Goldsmith et al.
CANCER LETTERS (2005)
Prospects for therapeutic inhibition of neuroblastoma angiogenesis
S Shusterman et al.
CANCER LETTERS (2005)
Interferon-mediated anti-angiogenic therapy for neuroblastoma
CJ Streck et al.
CANCER LETTERS (2005)
The in vitro and in vivo effects of JNJ-7706621:: A dual inhibitor of cyclin-dependent kinases and aurora kinases
S Emanuel et al.
CANCER RESEARCH (2005)
Cadherins and catenins in breast cancer
P Cowin et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Metalloproteinases and their inhibitors in tumor angiogenesis
MM Handsley et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Phase I pharmacokinetic and pharmacodynarnic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
U Banerji et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Survivin as a target for new anticancer interventions
N Zaffaroni et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
TIMP-2: an endogenous inhibitor of angiogenesis
WG Stetler-Stevenson et al.
TRENDS IN MOLECULAR MEDICINE (2005)
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
K Gumireddy et al.
CANCER CELL (2005)
Altered expression of cell cycle genes distinguishes aggressive neuroblastoma
AL Krasnoselsky et al.
ONCOGENE (2005)
Low expression of Wnt-5a gene is associated with high-risk neuroblastoma
E Blanc et al.
ONCOGENE (2005)
Decorin prevents metastatic spreading of breast cancer
CC Reed et al.
ONCOGENE (2005)
Polo-like kinases and oncogenesis
F Eckerdt et al.
ONCOGENE (2005)
p73-alpha is capable of inducing scotin and ER stress
A Terrinoni et al.
ONCOGENE (2004)
Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas
S Kim et al.
JOURNAL OF PEDIATRIC SURGERY (2004)
The significance of the Wnt pathway in the pathology of human cancers
RZ Karim et al.
PATHOLOGY (2004)
Convergence of Wnt, β-catenin, and cadherin pathways
WJ Nelson et al.
SCIENCE (2004)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
WNT and β-catenin signalling:: Diseases and therapies
RT Moon et al.
NATURE REVIEWS GENETICS (2004)
Promotion of neurite and filopodium formation by CD47: Roles of integrins, Rac, and Cdc42
M Miyashita et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors:: Role for CD8+ T cells
R Salcedo et al.
JOURNAL OF IMMUNOLOGY (2004)
Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4
WT Watford et al.
IMMUNOLOGICAL REVIEWS (2004)
Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol
GI Shapiro
CLINICAL CANCER RESEARCH (2004)
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma
JS Wei et al.
CANCER RESEARCH (2004)
Caspase 3 and 8 deficiency in human neuroblastoma
A Iolascon et al.
CANCER GENETICS AND CYTOGENETICS (2003)
N-myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation
YC Deng et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Lats2, a putative tumor suppressor, inhibits G1/S transition
YF Li et al.
ONCOGENE (2003)
Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity
B Wang et al.
CANCER CELL (2003)
Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity
DT Dang et al.
ONCOGENE (2003)
Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-Bet through activation of STAT1 during initial Th1 commitment
A Takeda et al.
JOURNAL OF IMMUNOLOGY (2003)
Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice
WW Spurbeck et al.
CANCER GENE THERAPY (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Geldanamycin decreases Raf-1 and Akt levels and induces apoptosis in neuroblastomas
S Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Differential regulation of protein expression, growth and apoptosis by natural and synthetic retinoids
MAC Pratt et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Cadherins as modulators of cellular phenotype
MJ Wheelock et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2003)
Advances in the diagnosis and treatment of neuroblastoma
JL Weinstein et al.
ONCOLOGIST (2003)
Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model
WW Spurbeck et al.
BLOOD (2002)
Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-γ and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2
JM Wigginton et al.
JOURNAL OF IMMUNOLOGY (2002)
Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes
K Wong et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors
M Lastowska et al.
GENES CHROMOSOMES & CANCER (2002)
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R
C Parham et al.
JOURNAL OF IMMUNOLOGY (2002)
Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays
C Sotiriou et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2002)
Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways
SL Shankar et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma
T Shimizu et al.
JOURNAL OF PEDIATRIC SURGERY (2001)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma
CM van Golen et al.
CELL DEATH AND DIFFERENTIATION (2000)
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
T Teitz et al.
NATURE MEDICINE (2000)
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
A Islam et al.
ONCOGENE (2000)
分享论文
